, Volume 39, Issue 2, pp 117–124 | Cite as

Transmissible spongiform encephalopathies and tissue cell culture

  • D. N. Galbraith


The discovery of prion proteins and the diseases which are associated with them still present scientists and clinicians with a number of problems. There are clearly risks with the use of living cells and materials of animal origin to produce therapeutic compounds with respect to the transmission of prion protein. However the medical benefit many of these compounds has to be weighed against this. It is clear a number of groups are continuing to unravel the highly complex relationships of prion biology and pathology and it is only when this is clearly established that the community can decide on these issues. Until this time the scientific community must rely on the best research available and provide guidance from this.

detection methods risk assessment spongiform encephalopathies 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Baron H, Safar J, Groth D, DeArmond SJ and Prusiner SB (1999) 'Biosafety Issues in Prion Diseases', in SB Prusiner (ed.) Prion Biology and Disease, Cold Spring Harbour University Press.Google Scholar
  2. Borchelt DR, Scott M, Taraboulos A, Stahl N and Preusiner SB (1990) Scrapie and cellular prion proteins differ in their kinetics of synthesis and topology in cultured cells. J C B 110: 743-752.Google Scholar
  3. Brown P, Gibbs CJ, Rodgers-Johnson P, Asher DM, Sulima MP, Bacote A, Goldfarb LG and Gajdusek DC (1994) Human spongiform encephalopathy: The National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol 35: 513-529.PubMedCrossRefGoogle Scholar
  4. Brown P (1995) Can Creutzfeldt-Jakob disease be transmitted by transfusion? Curr Opin in Haematol 2: 472-477.Google Scholar
  5. Brown P (1996) 'Environmental Causes of Human Spongiform Encephalopathy', in HF Baker and RM Ridley (eds), Prion Diseases (pp. 139-154), Humana Press, Totowa, United States.Google Scholar
  6. Butler DA, Scott MRD, Bockman JM, Borchelt DR, Taraboulos A, Hsiao KK, Kingsbury DT and Prusiner SB (1988) Scrapie infected murine neuroblastoma cells produce protease-resistant prion proteins. J Virol 62: 1558-1564.PubMedGoogle Scholar
  7. Committee for Proprietary Medicinal Products: Ad Hoc Working Party on Biotechnology/Pharmacy and Working Party on SafetyGoogle Scholar
  8. Medicines (1992) EEC Regulatory Document. Note for guidance. Guidelines for minimizing the risk of transmitting agents causing spongiform encephalopathy via medicinal products. Biologicals 20: 155-158.Google Scholar
  9. Cuille J and Chelle PL (1939) Experimental transmission of trembling to the goat. C. R. Seances Acad Sci 208: 1058-1060.Google Scholar
  10. Duffy P, Wolf J, Collins G, DeVoe AG, Streeten B and Cowan D (1974) Possible person to person transmission of Creutzfeldt-Jakob disease. N Engl J Med 290: 692-693.PubMedGoogle Scholar
  11. Gadjusek DC (1988) Transmissible and non-transmissible amyloidoses: Autocatalytic post-translational conversion of host precursor proteins to beta pleated confirmations. J Neuroimmunol 20: 95-110.Google Scholar
  12. Gabriel JM, Oesch B, Kretzschmar H, Scott M and Prusiner SB (1992) Molecular cloning of candidate chicken prion protein. Proc Natl Acad Sci USA 89: 9097-9101.PubMedCrossRefGoogle Scholar
  13. Kaneko K, Zulianello L, Scott M, Cooper CM, Wallace AC, James TL, Cohen FE and Presiner SB (1997) Evidence for protein X binding to a discontinuous epitope on the cellular prion protein during scrapie prion propigation. Proc Natl Acad Sci USA 94: 10069-10074.PubMedGoogle Scholar
  14. Kascsak RJ, Rubenstein R, Merz PA, Tonna-DeMasi M, Fersko R, Carp RI, Wisniewski HM and Diringer H (1987) Mouse polyclonal and monoclonal antibody to scrapie associated fibril proteins. J Virol 61: 3688-3693.PubMedGoogle Scholar
  15. Kasper KC, Bowman KA, Stites DP and Prusiner SB (1981) 'Toward Development of Assays for Scrapie Specific Antibodies', in JW Steilen (ed.) Hamster Immune Responses in Infectious and Oncologic Diseases (pp. 401-413).Google Scholar
  16. Kretzschmar HA, Prusiner SB, Stowring LE and DeArmond SJ (1986) Scrapie prion proteins are synthesised in neurons. Am J Pathol 122: 1-5.PubMedGoogle Scholar
  17. Lasmezas CI, Deslys JP, Demalmay R, Adjou KT, Lamoury F, Dormont D, Robain O, Ironside JW and Hauw JJ (1996) BSE transmission to macaques. Nature 381: 743-744.PubMedGoogle Scholar
  18. Manuelidis EE, De Figueiredo JM, Kim JH, Fritch WW and Manuelidis L (1988) Transmission to animals of CJD from human bloot. Lancet 2: 896-897.Google Scholar
  19. Pattison IH and Millson GC (1961) Further experimental observations on Scrapie. J Comp Pathol 71: 350-359.PubMedGoogle Scholar
  20. Saborio GP, Permanne B and Soto C (2001) Sensitive detection of pathological prion protein by cyclic amplificatiuon of protein misfolding. Nature 14: 810-813.Google Scholar
  21. Schatzl HM, Da Costa M, Taylor L, Cohen FE and Prusiner SB (1995) Prion protein gene variation among primates. J Mol Biol 245: 10962-10966.Google Scholar
  22. Schatzl HM, Laszlo L, Holtzman DM, Tatzelt J, DeArmond SJ, Weiner RI, Mobley WC and Prusiner SB (1997) A hypothalamic neuronal cell line persistently infected with Scrapie prions exhibits apoptosis. J Virol 71: 8821-8831.PubMedGoogle Scholar
  23. Tateishi J, Kitamoto T, Hoque MZ and Furukawa H (1999) Experimental transmission of Creutzfelt-Jakob disease and related diseases in rodents. Neurology 46: 532-537.Google Scholar
  24. Wells GA, Scott AC, Johnson CT, Gunning RF, Hancock RD, Jeffrey M, Dawson M and Bradley R (1987) A novel progressive spongiform encephalopathy in cattle. Vet Rec 121, 419-420.PubMedGoogle Scholar
  25. Wilesmith JW, Ryan JB and Atkinson MJ (1991) Bovine spongiform encephalopathy: Epidemiological studies on its origin. Vet Rec 123: 638-644.Google Scholar
  26. Will RG, Alpers MP, Dormont D, Schonberger LB and Tateishi J (1999) 'Infectious and Sporadic Prion Disease', in SB Prusiner (ed.) Prion Biology and Disease, Cold Spring Harbour University Press.Google Scholar

Copyright information

© Kluwer Academic Publishers 2002

Authors and Affiliations

  • D. N. Galbraith
    • 1
  1. 1.West of Scotland Science ParkTechnical Services and Regulatory Affairs, Q-One Biotech Ltd., Todd CampusGlasgowU.K

Personalised recommendations